Literature DB >> 33493880

Cervical disc arthroplasty versus anterior cervical discectomy and fusion for the treatment of single-level disc degenerative disease with preoperative reversible kyphosis.

Xu Hu1, Hao Liu1, Beiyu Wang2, Ying Hong3, Xin Rong1, Dan Pu4, Kangkang Huang1.   

Abstract

OBJECTIVE: Whether and when cervical disc arthroplasty (CDA) could be indicated for preoperative cervical spine kyphosis is unclear. The purpose of the study was to compare the clinical and radiological outcomes of single-level CDA and single-level anterior cervical discectomy and fusion (ACDF) in the patient with preoperative reversible kyphosis. PATIENTS AND METHODS: From 2014-2018, patients who underwent single-level CDA and single-level ACDF were consecutively reviewed. The Japanese Orthopedic Association score, Neck Disability Index and VAS were used to evaluate clinical outcomes. Range of motion (ROM), C2-7 Cobb angle, functional spinal unit (FSU) angle, and heterotopic ossification (HO) were assessed.
RESULTS: Thirty-eight CDA patients (a mean follow-up of 39.8 months) and 42 ACDF patients (37.6 months) with preoperative reversible kyphosis were included. Both groups had significant improvements in clinical outcomes, without statistically significant differences. Before surgery, there was no significant difference in cervical alignment and ROM between groups. After surgery, both groups had a significant increase in C2-7 angle and FSU without significant inter-group differences. At the last follow-up, CDA group consisted of 5 cases of lordosis, 11 cases of kyphosis and 22 cases of straight spine, while the corresponding case number in ACDF group was 4, 12 and 26 (P = 0.866). The C2-7 ROM was preserved in both groups. The segmental ROM of CDA group decreased mildly from 8.3° preoperatively to 5.1° finally, whereas the segmental ROM of ACDF group decreased significantly to nearly zero. 60.5 % (23/38) patients in CDA group developed HO with 9 levels of grade Ⅲ and 3 levels of grade Ⅳ.
CONCLUSION: For the patients with single-level disc degenerative disease and preoperative reversible kyphosis, both CDA and ACDF achieved satisfactory and comparable clinical results. CDA was non-inferior to ACDF regarding the radiological outcomes of cervical alignment. Patients in CDA group had a relatively high incidence of HO formation.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ACDF; Cervical disc arthroplasty; Heterotopic ossification; Reversible kyphosis

Mesh:

Year:  2021        PMID: 33493880     DOI: 10.1016/j.clineuro.2021.106493

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  5 in total

1.  Single-level cervical disc arthroplasty in the spine with reversible kyphosis: A finite element study.

Authors:  Xu Hu; Majiao Jiang; Ying Hong; Xin Rong; Kangkang Huang; Hao Liu; Dan Pu; Beiyu Wang
Journal:  JOR Spine       Date:  2022-02-08

Review 2.  A meta-analysis comparing the short- and mid- to long-term outcomes of artificial cervical disc replacement(ACDR) with anterior cervical discectomy and fusion (ACDF) for the treatment of cervical degenerative disc disease.

Authors:  Zihan Peng; Ying Hong; Yang Meng; Hao Liu
Journal:  Int Orthop       Date:  2022-02-03       Impact factor: 3.479

3.  Comparison of Radiographic Reconstruction and Clinical Improvement between Artificial Cervical Disc Replacement and Anterior Cervical Discectomy and Fusion.

Authors:  Yuxiang Chen; Yue Li; Yong Hai; Peng Yin; Yuzeng Liu; Jincai Yang; Qingjun Su
Journal:  Pain Res Manag       Date:  2022-01-24       Impact factor: 3.037

4.  Reply to Commentary on "Impact of Nonlordotic Sagittal Alignment on Short-term Outcomes of Cervical Disc Replacement".

Authors:  Avani S Vaishnav; Sheeraz A Qureshi
Journal:  Neurospine       Date:  2021-06-30

5.  Commentary on "Impact of Nonlordotic Sagittal Alignment on Short-term Outcomes of Cervical Disc Replacement".

Authors:  Kerui Zhang; Hao Liu; Tingkui Wu
Journal:  Neurospine       Date:  2021-06-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.